BESPOKE EXTRACTS, INC.

BSPK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Revenue $467.9K $390.6K $263.2K $301.4K $277.5K $278.2K $260.4K $263.8K
Cost of Revenue $233.8K $193.1K $152.4K $172.1K $162.5K $172.0K $157.8K $100.4K
Gross Profit $234.2K $197.5K $110.8K $129.2K $115.0K $106.1K $102.6K $163.4K
Gross Margin 50.0% 50.6% 42.1% 42.9% 41.4% 38.1% 39.4% 61.9%
Operating Expenses
Research & Development
SG&A Expense $260.2K $337.6K $313.2K $244.2K $361.4K $325.9K $347.9K $407.1K
Operating Income $-53.9K $-162.0K $-245.3K $-179.1K $-262.5K $-250.2K $-302.8K $-264.9K
Operating Margin -11.5% -41.5% -93.2% -59.4% -94.6% -90.0% -116.3% -100.4%
Interest Expense $4.2K $4.2K $0 $0
Pretax Income $-78.1K $-205.1K $-260.5K $-186.8K $-275.6K $-260.9K $-314.1K $-275.8K
Income Tax Expense
Net Income $-78.1K $-205.1K $-260.5K $-186.8K $-275.6K $-260.9K $-314.1K $-275.8K
Net Margin -16.7% -52.5% -99.0% -62.0% -99.3% -93.8% -120.6% -104.5%
EPS (Basic) $-0.01 $-0.02 $-0.02 $-0.01 $-0.03 $-0.03 $-0.03 $-0.03
EPS (Diluted) $-0.01 $-0.02 $-0.02 $-0.01 $-0.03 $-0.03 $-0.03 $-0.03
Shares Outstanding (Basic) 11.2M 11.2M 11.2M 10.5M 10.6M 10.2M 10.2M 10.2M
Shares Outstanding (Diluted) 11.2M 11.2M 11.2M 10.5M 10.6M 10.2M 10.2M 10.2M
Dividends Per Share
← Newer Page 1 of 2 Older →